DocGo Inc.'s (NASDAQ:DCGO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
DocGo Inc.'s (NASDAQ:DCGO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at DocGo's (NASDAQ:DCGO) recent performance, when its stock has declined 19% over the past three months. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Specifically, we decided to study DocGo's ROE in this article.
看了DocGo(纳斯达克股票代码:DCGO)最近的表现,很难感到兴奋,当时其股票在过去三个月中下跌了19%。但是,该公司的基本面看起来相当不错,长期财务状况通常与未来的市场价格走势一致。具体而言,我们决定在本文中研究DocGo的投资回报率。
Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
股本回报率或投资回报率是用于评估公司管理层利用公司资本效率的关键衡量标准。简而言之,它用于评估公司相对于其股权资本的盈利能力。
Check out our latest analysis for DocGo
看看我们对DocGo的最新分析
How Do You Calculate Return On Equity?
你如何计算股本回报率?
Return on equity can be calculated by using the formula:
股本回报率可以使用以下公式计算:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股本回报率 = 净利润(来自持续经营)÷ 股东权益
So, based on the above formula, the ROE for DocGo is:
因此,根据上述公式,DocGo的投资回报率为:
3.2% = US$9.2m ÷ US$292m (Based on the trailing twelve months to September 2023).
3.2% = 920万美元 ÷ 2.92亿美元(基于截至2023年9月的过去十二个月)。
The 'return' is the profit over the last twelve months. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.03 in profit.
“回报” 是过去十二个月的利润。另一种思考方式是,每持有价值1美元的股权,该公司就能获得0.03美元的利润。
Why Is ROE Important For Earnings Growth?
为什么投资回报率对收益增长很重要?
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.
到目前为止,我们已经了解到,ROE衡量的是公司创造利润的效率。然后,根据公司对这些利润进行再投资或 “保留” 的金额及其有效性,我们就能评估公司的盈利增长潜力。一般而言,在其他条件相同的情况下,股本回报率和利润保留率高的公司比不具备这些属性的公司的增长率更高。
DocGo's Earnings Growth And 3.2% ROE
DocGo的收益增长和3.2%的投资回报率
It is hard to argue that DocGo's ROE is much good in and of itself. Not just that, even compared to the industry average of 11%, the company's ROE is entirely unremarkable. In spite of this, DocGo was able to grow its net income considerably, at a rate of 61% in the last five years. Therefore, there could be other reasons behind this growth. Such as - high earnings retention or an efficient management in place.
很难说DocGo的投资回报率本身就非常好。不仅如此,即使与行业平均水平的11%相比,该公司的投资回报率也完全不引人注目。尽管如此,DocGo还是能够大幅增长其净收入,在过去五年中增长了61%。因此,这种增长背后可能还有其他原因。例如——高收益留存率或实行高效管理。
Next, on comparing with the industry net income growth, we found that DocGo's growth is quite high when compared to the industry average growth of 8.5% in the same period, which is great to see.
接下来,与行业净收入增长相比,我们发现与同期8.5%的行业平均增长率相比,DocGo的增长相当高,这真是太好了。
![past-earnings-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240104/0-024228a50ff0ef364b257a22ef0ca146-0-2b62384476c42d4b47c16c2e1027cb03.png/big)
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is DocGo fairly valued compared to other companies? These 3 valuation measures might help you decide.
收益增长是对股票进行估值时要考虑的重要指标。无论如何,投资者应设法确定预期的收益增长或下降是否已计入其中。然后,这可以帮助他们确定股票是面向光明还是暗淡的未来。与其他公司相比,DocGo的估值是否合理?这3种估值指标可能会帮助您做出决定。
Is DocGo Using Its Retained Earnings Effectively?
DocGo是否有效地使用了其留存收益?
DocGo doesn't pay any dividend to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.
DocGo不向其股东支付任何股息,这意味着该公司一直在将其所有利润再投资于该业务。这可能是推动上述高收益增长数字的原因。
Summary
摘要
On the whole, we do feel that DocGo has some positive attributes. With a high rate of reinvestment, albeit at a low ROE, the company has managed to see a considerable growth in its earnings. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.
总的来说,我们确实认为DocGo有一些积极的属性。尽管投资回报率很低,但由于再投资率很高,该公司的收益实现了可观的增长。话虽如此,从分析师目前的估计来看,我们发现该公司的收益有望增强。这些分析师的预期是基于对该行业的广泛预期,还是基于公司的基本面?点击此处进入我们分析师对公司的预测页面。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。